Drug Profile
Flovagatran
Alternative Names: Flovagatran-sodium; TGN-255Latest Information Update: 12 Dec 2010
Price :
$50
*
At a glance
- Originator Trigen Holdings AG
- Class Anticoagulants; Antithrombotics; Boronic acids; Small molecules
- Mechanism of Action Thrombin inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Thrombosis
Most Recent Events
- 07 Dec 2010 Discontinued - Phase-II for Thrombosis in Italy (IV)
- 07 Dec 2010 Discontinued - Phase-II for Thrombosis in Poland (IV)
- 07 Dec 2010 Discontinued - Phase-II for Thrombosis in United Kingdom (IV)